Who was responsible for the introduction of psychotropic medications in mental healthcare?

Choice A reason: The National League for Nursing focuses primarily on establishing standards for nursing education and faculty development. While they influence how psychiatric nursing is taught, they do not possess the biochemical research infrastructure or the regulatory mandate required to develop or introduce new pharmacological agents into clinical practice. Choice B reason: Community Mental Health Centers were established largely as a result of the deinstitutionalization movement to provide outpatient services. While these centers are primary sites for the administration and monitoring of psychotropic drugs, they are consumers of these medical advancements rather than the entities responsible for their initial development. Choice C reason: The pharmaceutical industry led the psychopharmacological revolution in the 1950s, starting with the discovery of chlorpromazine. Private laboratories and chemical companies conducted the primary research, clinical trials, and mass production required to introduce antipsychotics, antidepressants, and mood stabilizers that fundamentally changed the trajectory of mental healthcare. Choice D reason: The American Nurses Association is a professional organization dedicated to advancing the nursing profession and advocating for patient safety and health policy. While the ANA supports the integration of evidence-based medicine into nursing care, it is not a scientific body involved in drug discovery.